A Lower dosage of imatinib is sufficient to maintain undetectable disease in patients with chronic myeloid leukemia with long-term LOW-grade toxicity of the treatment.
LEUKEMIA & LYMPHOMA（2016）
关键词
Chronic myeloid leukemia,imatinib,minimal residual disease,side effects
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要